The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

Agilis Biotherapeutics LLC / See Company Profile

Acquisition / PTC adds gene therapy candidates through $945mm buy of Agilis / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 31, 2018

Alliance / Agilis licenses NTU's AADC deficiency gene therapy / Strategic Transactions / Deal Date: Jan. 1, 2016 / Publish Date: Feb. 4, 2016

Alliance / USF grants Agilis license to Angelman syndrome gene candidates / Strategic Transactions / Deal Date: May 1, 2015 / Publish Date: May 19, 2015

TxCell SA / See Company Profile

Acquisition / Sangamo to acquire TxCell for €65.8mm / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Aug. 1, 2018

Alliance / TxCell exclusively licenses CAR-treg patent from Yeda Research & Development / Strategic Transactions / Deal Date: Nov. 1, 2015 / Update Date: Jun. 1, 2016

Alliance / TxCell grants Ferring option on lead IBD candidate Ovasave; assigned to Trizell; terminated / Strategic Transactions / Deal Date: Mar. 1, 2014 / Update Date: Dec. 1, 2015

SQZ Biotechnologies Co. / See Company Profile

Financing / Oversubscribed Series C round garners $72mm for SQZ Biotechnologies / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 9, 2018

Financing / SQZ Biotechnologies brings in $15.7mm through Series B round / Strategic Transactions / Deal Date: Sep. 1, 2016 / Publish Date: Oct. 7, 2016

Alliance / Roche signs autologous cell therapy deal with SQZ / Strategic Transactions / Deal Date: Dec. 1, 2015 / Publish Date: Dec. 8, 2015


Medical Devices

Email Alert | RSS Feed

Claret Medical Inc. / See Company Profile

Acquisition / Boston Scientific acquires Claret for $270mm, including earn-out / Strategic Transactions / Deal Date: Jul. 1, 2018 / Update Date: Aug. 1, 2018

Financing / Claret closes $14.5mm Series C / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 23, 2017

Financing / Series A lands $3.5mm for Claret Medical / Strategic Transactions / Deal Date: Aug. 1, 2011 / Publish Date: Sep. 11, 2014

Tandem Diabetes Care Inc. / See Company Profile

Financing / Public offering nets $109.3mm for Tandem Diabetes / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 9, 2018

Financing / Tandem Diabetes Care nets $64.9mm via FOPO / Strategic Transactions / Deal Date: Feb. 1, 2018 / Publish Date: Feb. 13, 2018

Financing / Tandem Diabetes Care nets $15.15mm via follow-on / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 18, 2017

RTI Surgical Inc. / See Company Profile

Alliance / RTI Surgical to distribute Aziyo's ViBone in the US / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 2, 2018

Acquisition / RTI Surgical buys spinal device maker Zyga Technology / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Jan. 9, 2018

Acquisition / RTI Surgical sells cardiothoracic closure biz to A&E / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 9, 2017


In Vitro Diagnostics

Email Alert | RSS Feed

NeoGenomics Inc. / See Company Profile

Financing / Public offering nets $117.5mm for NeoGenomics / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 10, 2018

Financing / NeoGenomics enters $150mm senior credit facility; gets $97.9mm at closing / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 24, 2016

Acquisition / NeoGenomics acquires Clarient for $277mm in cash and stock / Strategic Transactions / Deal Date: Oct. 1, 2015 / Publish Date: Oct. 22, 2015

Integrated Diagnostics Inc. / See Company Profile

Acquisition / Biodesix acquires Integrated Diagnostics / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 10, 2018

Financing / Integrated Diagnostics closes financing of equity and debt / Strategic Transactions / Deal Date: Apr. 1, 2014 / Publish Date: Apr. 30, 2014

Financing / Integrated Diagnostics begins operations with $30mm Series A / Strategic Transactions / Deal Date: Oct. 1, 2009 / Update Date: Feb. 1, 2012

Natera Inc. / See Company Profile

Financing / Natera nets $84.6mm through FOPO / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 13, 2018

Financing / Natera enters $100mm debt facility with OrbiMed; draws down $75mm / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 10, 2017

Financing / Natera goes public with $167.4mm IPO / Strategic Transactions / Deal Date: Jul. 1, 2015 / Publish Date: Jul. 2, 2015


Pharmaceuticals

Email Alert | RSS Feed

Oxford BioMedica PLC / See Company Profile

Alliance / Boehringer secures option for cystic fibrosis gene therapy from Oxford BioMedica / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 8, 2018

Alliance / Axovant gains worldwide license to Oxford BioMedica's OXB102 gene therapy candidate for PD / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 8, 2018

Alliance / Bioverativ gets rights to Oxford BioMedica's LentiVector tech for hemophilia therapies / Strategic Transactions / Deal Date: Feb. 1, 2018 / Publish Date: Feb. 22, 2018

Zogenix Inc. / See Company Profile

Financing / Zogenix FOPO brings in $293mm / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 10, 2018

Financing / Zogenix nets $271.6mm in oversubscribed FOPO / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 5, 2017

Alliance / Endo licenses worldwide rights to Zogenix’s Sumavel DosePro; deal terminated / Strategic Transactions / Deal Date: Apr. 1, 2014 / Update Date: Apr. 1, 2017

Adamis Pharmaceuticals Corp. / See Company Profile

Financing / Adamis nets $37.8mm via FOPO / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 3, 2018

Financing / Adamis nets $16.2mm via FOPO / Strategic Transactions / Deal Date: Apr. 1, 2017 / Publish Date: Apr. 25, 2017

Financing / Adamis raises $10.4mm through RDO to help fund NDA resubmission / Strategic Transactions / Deal Date: Jul. 1, 2016 / Publish Date: Aug. 1, 2016

Biotechnology

Biotechnology

Email Alert | RSS Feed

Agilis Biotherapeutics LLC / See Company Profile

Acquisition / PTC adds gene therapy candidates through $945mm buy of Agilis / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 31, 2018

Alliance / Agilis licenses NTU's AADC deficiency gene therapy / Strategic Transactions / Deal Date: Jan. 1, 2016 / Publish Date: Feb. 4, 2016

Alliance / USF grants Agilis license to Angelman syndrome gene candidates / Strategic Transactions / Deal Date: May 1, 2015 / Publish Date: May 19, 2015

TxCell SA / See Company Profile

Acquisition / Sangamo to acquire TxCell for €65.8mm / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Aug. 1, 2018

Alliance / TxCell exclusively licenses CAR-treg patent from Yeda Research & Development / Strategic Transactions / Deal Date: Nov. 1, 2015 / Update Date: Jun. 1, 2016

Alliance / TxCell grants Ferring option on lead IBD candidate Ovasave; assigned to Trizell; terminated / Strategic Transactions / Deal Date: Mar. 1, 2014 / Update Date: Dec. 1, 2015

SQZ Biotechnologies Co. / See Company Profile

Financing / Oversubscribed Series C round garners $72mm for SQZ Biotechnologies / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 9, 2018

Financing / SQZ Biotechnologies brings in $15.7mm through Series B round / Strategic Transactions / Deal Date: Sep. 1, 2016 / Publish Date: Oct. 7, 2016

Alliance / Roche signs autologous cell therapy deal with SQZ / Strategic Transactions / Deal Date: Dec. 1, 2015 / Publish Date: Dec. 8, 2015

Medical
Devices

Medical Devices

Email Alert | RSS Feed

Claret Medical Inc. / See Company Profile

Acquisition / Boston Scientific acquires Claret for $270mm, including earn-out / Strategic Transactions / Deal Date: Jul. 1, 2018 / Update Date: Aug. 1, 2018

Financing / Claret closes $14.5mm Series C / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 23, 2017

Financing / Series A lands $3.5mm for Claret Medical / Strategic Transactions / Deal Date: Aug. 1, 2011 / Publish Date: Sep. 11, 2014

Tandem Diabetes Care Inc. / See Company Profile

Financing / Public offering nets $109.3mm for Tandem Diabetes / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 9, 2018

Financing / Tandem Diabetes Care nets $64.9mm via FOPO / Strategic Transactions / Deal Date: Feb. 1, 2018 / Publish Date: Feb. 13, 2018

Financing / Tandem Diabetes Care nets $15.15mm via follow-on / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 18, 2017

RTI Surgical Inc. / See Company Profile

Alliance / RTI Surgical to distribute Aziyo's ViBone in the US / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 2, 2018

Acquisition / RTI Surgical buys spinal device maker Zyga Technology / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Jan. 9, 2018

Acquisition / RTI Surgical sells cardiothoracic closure biz to A&E / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 9, 2017

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

NeoGenomics Inc. / See Company Profile

Financing / Public offering nets $117.5mm for NeoGenomics / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 10, 2018

Financing / NeoGenomics enters $150mm senior credit facility; gets $97.9mm at closing / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 24, 2016

Acquisition / NeoGenomics acquires Clarient for $277mm in cash and stock / Strategic Transactions / Deal Date: Oct. 1, 2015 / Publish Date: Oct. 22, 2015

Integrated Diagnostics Inc. / See Company Profile

Acquisition / Biodesix acquires Integrated Diagnostics / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 10, 2018

Financing / Integrated Diagnostics closes financing of equity and debt / Strategic Transactions / Deal Date: Apr. 1, 2014 / Publish Date: Apr. 30, 2014

Financing / Integrated Diagnostics begins operations with $30mm Series A / Strategic Transactions / Deal Date: Oct. 1, 2009 / Update Date: Feb. 1, 2012

Natera Inc. / See Company Profile

Financing / Natera nets $84.6mm through FOPO / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 13, 2018

Financing / Natera enters $100mm debt facility with OrbiMed; draws down $75mm / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 10, 2017

Financing / Natera goes public with $167.4mm IPO / Strategic Transactions / Deal Date: Jul. 1, 2015 / Publish Date: Jul. 2, 2015

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Oxford BioMedica PLC / See Company Profile

Alliance / Boehringer secures option for cystic fibrosis gene therapy from Oxford BioMedica / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 8, 2018

Alliance / Axovant gains worldwide license to Oxford BioMedica's OXB102 gene therapy candidate for PD / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 8, 2018

Alliance / Bioverativ gets rights to Oxford BioMedica's LentiVector tech for hemophilia therapies / Strategic Transactions / Deal Date: Feb. 1, 2018 / Publish Date: Feb. 22, 2018

Zogenix Inc. / See Company Profile

Financing / Zogenix FOPO brings in $293mm / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 10, 2018

Financing / Zogenix nets $271.6mm in oversubscribed FOPO / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 5, 2017

Alliance / Endo licenses worldwide rights to Zogenix’s Sumavel DosePro; deal terminated / Strategic Transactions / Deal Date: Apr. 1, 2014 / Update Date: Apr. 1, 2017

Adamis Pharmaceuticals Corp. / See Company Profile

Financing / Adamis nets $37.8mm via FOPO / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 3, 2018

Financing / Adamis nets $16.2mm via FOPO / Strategic Transactions / Deal Date: Apr. 1, 2017 / Publish Date: Apr. 25, 2017

Financing / Adamis raises $10.4mm through RDO to help fund NDA resubmission / Strategic Transactions / Deal Date: Jul. 1, 2016 / Publish Date: Aug. 1, 2016

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel